Patents by Inventor Stephanie Blum-Sperisen

Stephanie Blum-Sperisen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10137108
    Abstract: Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: November 27, 2018
    Assignee: Nestec S.A.
    Inventors: Stephanie Blum-Sperisen, Magali Faure, Denis Breuille, Emil Chuang
  • Patent number: 10064426
    Abstract: The present invention relates to the use of probiotic on expecting female mammals to boost the immune status of an offspring. The use can induce an enhanced response of the offspring after birth to an infectious antigenic exposure. Ultimately the use of probiotic in expecting females can induce a better protection of their offspring against infectious diseases.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: September 4, 2018
    Assignee: Nestec S.A.
    Inventors: Jalil Benyacoub, Stephanie Blum-Sperisen, Florence Rochat, Thierry Von der Weid
  • Publication number: 20180037637
    Abstract: Probiotics and ways to increase their effectiveness are provided. One embodiment of the present invention relates to a combination of probiotics with SIgA and possible uses of this combination. For example a use of a composition comprising SIgA and at least one probiotic for the preparation of a product to treat or prevent inflammation is disclosed.
    Type: Application
    Filed: October 19, 2017
    Publication date: February 8, 2018
    Inventors: Jalil Benyacoub, Blaise Corthesy, Stephanie Blum-Sperisen, Laurent Favre
  • Publication number: 20180021278
    Abstract: Methods and compositions are provided that treat or prevent inflammation using serine. A therapeutically effective amount of serine is administered to an individual, for example a human or other mammal, that has inflammation or is at risk of inflammation. The methods and compositions can control and/or alleviate an inflammatory reaction of the body, such as colitis.
    Type: Application
    Filed: January 22, 2016
    Publication date: January 25, 2018
    Inventors: Magali Faure, Stephanie Blum-Sperisen, Mohamed Nabil Bosco, Viral Brahmbhatt, Denis Breuille
  • Publication number: 20170370910
    Abstract: The present invention relates to a method for determining the distinctive nutritional requirements of a patient with specific nutritional needs and providing a composition meeting the distinctive nutritional requirements of said patient.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Inventors: Serge Andre Dominique Rezzi, Stephanie Blum-Sperisen, Magali Faure, Denis Breuille
  • Publication number: 20170368026
    Abstract: Methods and compositions are provided that use proline, serine and threonine to promote healing of the intestinal mucosa. A therapeutically effective amount of proline, serine and threonine is administered to an individual in need thereof, for example a human or other mammal, such as an individual that has damaged intestinal mucosa. The methods and compositions can promote mucosal healing, restore gut barrier function, repair intestinal epithelial cells, promote protection of the colonic epithelium, and/or promote the replenishment of goblet cells in the intestinal and colonic mucosa.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Inventors: Magali Faure, Stephanie Blum-Sperisen, Mohamed Nabil Bosco, Viral Brahmbhatt, Denis Breuille
  • Publication number: 20170368027
    Abstract: Compositions and methods are provided that are useful in the treatment of inflammatory bowel disease (IBD) patients. The Compositions and methods are suitable in the prevention or postponement of a relapse in inflammatory bowel disease patients.
    Type: Application
    Filed: January 22, 2016
    Publication date: December 28, 2017
    Inventors: Stephanie Blum-Sperisen, Magali Faure, Denis Breuille, Emil Chuang
  • Patent number: 9822167
    Abstract: The present invention relates generally to the field of nutrition, health and wellness. In particular the present invention relates to probiotics and ways to increase their effectiveness. One embodiment of the present invention relates to a combination of probiotics with SIgA and possible uses of this combination. For example a use of a composition comprising SIgA and at least one probiotic for the preparation of a product to treat or prevent inflammation is disclosed.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: November 21, 2017
    Assignee: Nestec S.A.
    Inventors: Jalil Benyacoub, Blaise Corthesy, Stephanie Blum-Sperisen, Laurent Favre
  • Publication number: 20170281757
    Abstract: Ways to increase the effectiveness of probiotics are disclosed. One embodiment relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example, a method of using a composition containing secretory IgA and at least one probiotic to prepare a product to treat or prevent infection is disclosed.
    Type: Application
    Filed: March 24, 2017
    Publication date: October 5, 2017
    Inventors: Jalil Benyacoub, Blaise Corthesy, Stephanie Blum-Sperisen, Laurent Favre
  • Patent number: 9629908
    Abstract: Ways to increase the effectiveness of probiotics is disclosed. One embodiment relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example, a method of using a composition comprising secretory IgA and at least one probiotic to prepare a product to treat or prevent infection is disclosed.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: April 25, 2017
    Assignee: Nestec S.A.
    Inventors: Jalil Benyacoub, Blaise Corthesy, Stephanie Blum-Sperisen, Laurent Favre
  • Publication number: 20170006908
    Abstract: The present invention relates to the use of probiotic on expecting female mammals to boost the immune status of an offspring. The use can induce an enhanced response of the offspring after birth to an infectious antigenic exposure. Ultimately the use of probiotic in expecting females can induce a better protection of their offspring against infectious diseases.
    Type: Application
    Filed: August 8, 2016
    Publication date: January 12, 2017
    Inventors: Jalil Benyacoub, Stephanie Blum-Sperisen, Florence Rochat, Thierry Von der Weid
  • Patent number: 9456630
    Abstract: The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of bifidobacterium longum ATCC BAAA-999.
    Type: Grant
    Filed: April 20, 2012
    Date of Patent: October 4, 2016
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Stephanie Blum-Sperisen, Florence Rochat
  • Patent number: 9414621
    Abstract: The present invention relates to the use of probiotic on expecting female mammals to boost the immune status of offspring. The use can induce an enhanced response of the offspring after birth to an infectious antigenic exposure. Ultimately the use of probiotic in expecting females can induce a better protection of offspring against infectious diseases.
    Type: Grant
    Filed: March 11, 2009
    Date of Patent: August 16, 2016
    Assignee: Nestec S.A.
    Inventors: Jalil Benyacoub, Stephanie Blum-Sperisen, Florence Rochat, Thierry Von der Weid
  • Publication number: 20160106834
    Abstract: Ways to increase the effectiveness of probiotics is disclosed. One embodiment relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example, a method of using a composition comprising secretory IgA and at least one probiotic to prepare a product to treat or prevent infection is disclosed.
    Type: Application
    Filed: October 1, 2015
    Publication date: April 21, 2016
    Inventors: Jalil Benyacoub, Blaise Corthesy, Stephanie Blum-Sperisen, Laurent Favre
  • Patent number: 9226521
    Abstract: A nutritional composition is proposed comprising a probiotic and milk fat globule membrane (MFGM) wherein the MFGM and the probiotics mutually potentiate their respective effects and promote complementary beneficial protective mechanisms that reflect physiological synergy. The nutritional composition can be an infant formula, infant cereals, baby food or health care nutritional product. The synergistic effect can include promoting immune maturation and/or immune education and/or reducing inflammation and/or treating or preventing disease or infections.
    Type: Grant
    Filed: December 7, 2010
    Date of Patent: January 5, 2016
    Assignee: Nestec S.A.
    Inventors: Jalil Benyacoub, Stephanie Blum-Sperisen, Mohamed Nabil Bosco, Lionel Jean Rene Bovetto, Isabelle Bureau-Franz, Anne Donnet-Hughes, Eduardo Schiffrin, Laurent Favre
  • Patent number: 9173937
    Abstract: The present invention relates generally to the field of nutrition, health and wellness. In particular the present invention relates to probiotics and ways to increase their effectiveness. One embodiment of the present invention relates to a combination of probiotics with secretory IgA and possible uses of this combination. For example a use of a composition comprising secretory IgA and at least one probiotic for the preparation of a product to treat or prevent infection is disclosed.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: November 3, 2015
    Assignee: Nestec S.A.
    Inventors: Jalil Benyacoub, Blaise Corthesy, Stephanie Blum-Sperisen, Laurent Favre
  • Patent number: 9072769
    Abstract: The present invention relates in general to the field of inflammation. In particular the present invention relates to the use of natural compounds for the preparation of a product to treat or prevent inflammation. For example an extract of wolfberry was shown to have anti-inflammatory properties. One embodiment of the present invention relates to the use of a primary composition comprising wolfberries or a part thereof for the preparation of a product to treat or prevent inflammation.
    Type: Grant
    Filed: September 12, 2008
    Date of Patent: July 7, 2015
    Assignees: Nestec S.A., L'Oreal
    Inventors: Karine Vidal, Stephanie Blum-Sperisen, David Philippe, Olivier Ballevre, Peter Bucheli, Junkuan Wang
  • Patent number: 8916145
    Abstract: The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of bifidobacterium longum ATCC BAA-999.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: December 23, 2014
    Assignee: Nestec S.A.
    Inventors: Annick Mercenier, Stephanie Blum-Sperisen, Florence Rochat
  • Publication number: 20120321600
    Abstract: A nutritional composition is proposed comprising a probiotic and milk fat globule membrane (MFGM) wherein the MFGM and the probiotics mutually potentiate their respective effects and promote complementary beneficial protective mechanisms that reflect physiological synergy. The nutritional composition can be an infant formula, infant cereals, baby food or health care nutritional product. The synergistic effect can include promoting immune maturation and/or immune education and/or reducing inflammation and/or treating or preventing disease or infections.
    Type: Application
    Filed: December 7, 2010
    Publication date: December 20, 2012
    Applicant: NESTEC S.A.
    Inventors: Jalil Benyacoub, Stephanie Blum-Sperisen, Mohamed Nabil Bosco, Lionel Jean Rene Bovetto, Isabelle Bureau-Franz, Anne Donnet-Hughes, Eduardo Schiffrin, Laurent Favre
  • Publication number: 20120201785
    Abstract: The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of bifidobacterium longum ATCC BAAA-999.
    Type: Application
    Filed: April 20, 2012
    Publication date: August 9, 2012
    Applicant: Nestec S.A.
    Inventors: Annick Mercenier, Stephanie Blum-Sperisen, Florence Rochat